成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 153439-40-8 Chemical Structure| 153439-40-8
Chemical Structure| 153439-40-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 153439-40-8

,{[proInfo.pro_purity]}

Fexofenadine inhibits histamine H1 receptor with IC50 of 246 nM.

Synonyms: MDL-16455 hydrochloride; Terfenadine carboxylate hydrochloride; MDL 16455A

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Fexofenadine HCl

CAS No. :153439-40-8
Formula : C32H40ClNO4
M.W : 538.12
SMILES Code : CC(C)(C1=CC=C(C(O)CCCN2CCC(C(C3=CC=CC=C3)(O)C4=CC=CC=C4)CC2)C=C1)C(O)=O.[H]Cl
Synonyms :
MDL-16455 hydrochloride; Terfenadine carboxylate hydrochloride; MDL 16455A
MDL No. :MFCD00865710
InChI Key :RRJFVPUCXDGFJB-UHFFFAOYSA-N
Pubchem ID :63002

Safety of Fexofenadine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P233-P260-P261-P264-P270-P271-P280-P301+P312-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P330-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501

Related Pathways of Fexofenadine HCl

GPCR

Isoform Comparison

Biological Activity

Target
  • H1 receptor

    Histamine H1 receptor, IC50:246 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01375790 Aging Phase 3 Completed - Spain ... More >> Albada Centre Socio Sanitari Parc Taulí Sabadell, Babadell, Spain, 08208 Ballesol Badalona Badalona, Barcelona, Spain, 08911 Ballesol Barberà Barberà del Vallès, Barcelona, Spain, 08210 Residència Allegra Sabadell, Barcelona, Spain, 08203 Residència Poble Nou Barcelona, Spain, 08005 Ballesol Fabra i Puig Barcelona, Spain, 08016 Ballesol Almogàvers Barcelona, Spain, 08018 Residència Mapfre Quavitae Barcelona, Spain, 08025 Residència AMMA Horta Barcelona, Spain, 08035 Residència Collserola (Mutuam) Barcelona, Spain, 08035 Less <<
NCT02796898 Prostate Cancer ... More >> Rising Prostate Specific Antigen (PSA) Less << Phase 1 Phase 2 Recruiting December 31, 2019 United States, New Jersey ... More >> AdvanceMed Research Completed Lawrence, New Jersey, United States, 08648 United States, New York Montefiore Medical Center- Montefiore Medical Park Not yet recruiting Bronx, New York, United States, 10461 Contact: Gartrell Benjamin, MD ?? 718-405-8404 ?? bgartrel@montefiore.org ?? Eastchester Center for Cancer Care Recruiting Bronx, New York, United States, 10469 Contact: Carmen Vicuna ?? 718-732-4078 ?? cvicuna@nycancer.com ?? AccuMed Research Associates Recruiting Garden City, New York, United States, 11530-1664 Contact: Tammi Allegra, RN ?? 516-746-2190 ?? tallegra.accumedresearch@gmail.com ?? United States, Pennsylvania MidLantic Urology Recruiting Bala-Cynwyd, Pennsylvania, United States, 19004 Contact: Cheryl A Zinar, RN, BSN ?? 610-667-0458 ?? ?? Principal Investigator: Laurence H Belkoff, DO Less <<
NCT00078195 Hay Fever Hyp... More >>ersensitivity Allergy Rhinitis Less << Phase 2 Completed - United States, Iowa ... More >> University of Iowa Iowa City, Iowa, United States, 52242 United States, Nebraska Creighton University Omaha, Nebraska, United States, 68131 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53705 Less <<
NCT00866788 Chronic Idiopathic Urticaria Phase 2 Completed - -
NCT00670293 - Completed - United States, New York ... More >> New York State Psychiatric Institute New York, New York, United States, 10032 Less <<
NCT00866788 - Completed - -
NCT03181685 Infertility I... More >>n Vitro Fertilization Less << Phase 4 Recruiting December 2019 Italy ... More >> ANDROS Day Surgery Clinic, Reproductive Medicine Unit Recruiting Palermo, Italy, 90144 Contact: Angelo Marino, MD ?? +39 091 6785537 ?? angelo.marino@clinicaandros.it Less <<
NCT02438072 Depression Not Applicable Unknown December 2015 Switzerland ... More >> H?pitaux Universitaires de Genève Recruiting Genève, Switzerland, 1205 Contact: celia Lloret-Linares, MD, PhD ?? 0041 79 55 36 389 ?? celia.LloretLinares@hcuge.ch Less <<
NCT00096278 Adenocarcinoma of the Colon ... More >> Stage IIA Colon Cancer Stage IIB Colon Cancer Stage IIC Colon Cancer Stage IIIA Colon Cancer Stage IIIB Colon Cancer Stage IIIC Colon Cancer Less << Phase 3 Completed - United States, Pennsylvania ... More >> National Surgical Adjuvant Breast and Bowel Project Pittsburgh, Pennsylvania, United States, 15212-5234 Less <<
NCT03611985 Breast Cancer Phase 1 Phase 2 Not yet recruiting January 2022 United States, Florida ... More >> University of Florida Not yet recruiting Gainesville, Florida, United States, 32608 Contact: Allison Allegra, MPH ?? 352-273-5079 ?? allisonallegra3@ufl.edu ?? Principal Investigator: Coy Heldermon Less <<
NCT01850628 - Recruiting February 2020 United States, Florida ... More >> University of Florida Recruiting Gainesville, Florida, United States, 32610 Principal Investigator: Carmen Allegra, MD ?? ?? ?? United States, Missouri Washington University School of Medicine Recruiting St Louis, Missouri, United States, 63110 Principal Investigator: Adel Tabchy, MD ?? ?? ?? United States, New York New York University School of Medicine Recruiting New York, New York, United States, 10016 United States, Pennsylvania Allegheny General Hospital Recruiting Pittsburgh, Pennsylvania, United States, 15212 Principal Investigator: Thomas Julian, MD ?? ?? ?? United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Principal Investigator: Mothaffar Rimawi, MD Less <<
NCT01384994 Colorectal Cancer ... More >> KRAS Wildtype After Resection of Liver Metastases Less << Phase 2 Unknown August 2014 Germany ... More >> Ludwig-Maximilians - University of Munich Recruiting Munich, Germany, 81377 Contact: Volker Heinemann, Prof. Dr. med. ?? +49 89 7095 ext 0 ?? volker.heinemann@med.uni-muenchen.de ?? Contact: Clemens Giessen, Dr. med. ?? +49 89 7095 ext 0 ?? clemens.giessen@med.uni-muenchen.de ?? Principal Investigator: Volker Heinemann, Prof. Dr. med. Less <<
NCT02401191 Rhinitis Allergic Phase 3 Completed - Japan ... More >> Sanofi Administrative Office Tokyo, Japan Less <<
NCT00884325 Atopic Dermatitis ... More >> Pruritus Less << Phase 4 Completed - United States, Kentucky ... More >> DermResearch, PLLC Louisville, Kentucky, United States, 40217 Less <<
NCT00096278 - Completed - -
NCT00103012 - Completed - -
NCT00103012 Healthy Phase 4 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00606957 Obesity Not Applicable Completed - United States, New York ... More >> Rockefeller University New York, New York, United States, 10021 Less <<
NCT00080574 Thyroid Cancer Phase 2 Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less <<
NCT02435563 Healthy Phase 2 Completed - Switzerland ... More >> Centre de Recherche Clinique, HUG, Rue Gabrielle Perret-Gentil 4 Genève, Switzerland, 1211 Less <<
NCT01125644 Cryptococcosis or Aspergillosi... More >>s Infections Less << Phase 3 Unknown December 2011 Italy ... More >> Ospedale Maggiore di Milano IRCCS Policlinico Dipartimento Malattie Cardiovascolari e Respiratorie Recruiting Milan, Italy, 20122 Contact: Luigi Allegra, Ph.D ?? 39 02 55033781 ?? luigi.allegra@unimi.it ?? Principal Investigator: Francesco Blasi, MD Less <<
NCT01731067 Healthy Volunteers Phase 1 Completed - Switzerland ... More >> University Hospitals Geneva 14, Switzerland Less <<
NCT02590185 Major Depressive Disorders Not Applicable Recruiting April 2019 France ... More >> Fernand Widal hospital Recruiting Paris, France, 75010 Contact: Frank Bellivier, MD PhD ?? ?? frank.bellivier@inserm.fr ?? Lariboisiere hospital Recruiting Paris, France, 75010 Contact: celia Lloret-Linares, MD ?? ?? celia.lloret-linares@aphp.fr Less <<
NCT02966665 Chronic Obstructive Pulmonary ... More >>Disease Pulmonary Artery Hypertension Heart Failure Hypertension Less << Phase 1 Recruiting August 2020 United States, Utah ... More >> George E Wahlen VA Medical Center Recruiting Salt Lake City, Utah, United States, 84132 Contact: Russell Richardson, Ph.D. ?? 801-582-1565 ?? r.richardson@hsc.utah.edu ?? Contact: Ashley Nelson, MD ?? 801-582-1565 ext 4127 ?? ash.nelson@hsc.utah.edu Less <<
NCT01940393 Urticaria Phase 4 Completed - Colombia ... More >> Medellin Medellin, Antioquia, Colombia Less <<
NCT02592317 Prostatic Neoplasms, Castratio... More >>n-Resistant Less << Phase 1 Active, not recruiting August 1, 2019 Moldova, Republic of ... More >> Chisinau, Moldova, Republic of Spain Barcelona, Spain Sevilla, Spain Less <<
NCT02056743 Healthy Phase 1 Completed - Korea, Republic of ... More >> Clinical Trial Center of Chonbuk National University Hospital Jeonju, Jeollabuk-do, Korea, Republic of Less <<
NCT02360644 Chronic Kidney Diseases ... More >> Deficiency, Vitamin D Less << Not Applicable Recruiting August 2019 United States, Colorado ... More >> University of Colorado Not yet recruiting Aurora, Colorado, United States, 80045 Contact: Melanie Joy, Pharm D, PhD ?? 303-724-7416 ?? melanie.joy@ucdenver.edu ?? United States, Pennsylvania University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15261 Contact: Thomas Nolin, PharmD, PhD ?? 412-624-4683 ?? nolin@pitt.edu Less <<
NCT00884325 - Completed - -
NCT01683552 ITCH Phase 2 Completed - Italy ... More >> Campus Bio-Medico of Rome University Roma, Italy, 00128 Less <<
NCT00623701 Allergy Rhini... More >>tis Conjunctivitis Less << Phase 3 Completed - Germany ... More >> Prof. Kristian Reich, MD Hamburg, Germany, 20354 Less <<
NCT02391688 Drug Interaction Phase 1 Completed - Switzerland ... More >> Centre de Recherche Clinique, HUG, Rue Gabrielle Perret-Gentil 4 Genève, Switzerland, 1211 Less <<
NCT00562120 - Completed - -
NCT01852318 Uremic Pruritus Phase 4 Unknown May 2015 Taiwan ... More >> National Taiwan University (NTUH); NTUH Hsin-Chu Branch; NTUH Yun-Lin Branch; Cathay General hospital Not yet recruiting Taipei, Taiwan, 100; 300; 640; 280 Contact: Hsien-Yi Chiu, MD ?? 0972654317 ?? extra.owl0430@yahoo.com.tw ?? Principal Investigator: Hsien-Yi Chiu, MD Less <<
NCT00542607 Rhinitis, Allergic, Seasonal Phase 4 Completed - -
NCT00547768 Allergy Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT00562120 Allergic Rhinitis Phase 2 Completed - United States, Nebraska ... More >> Pfizer Investigational Site Omaha, Nebraska, United States, 68131 Less <<
NCT01033396 Allergic Rhinitis Phase 2 Completed - Canada, Ontario ... More >> Pfizer Investigational Site Kingston, Ontario, Canada, K7L 2V7 Less <<
NCT01244217 Rhinitis Perennial Phase 2 Phase 3 Completed - Japan ... More >> Sanofi-Aventis Investigational Site Number 392015 Fukuoka-Shi, Japan Sanofi-Aventis Investigational Site Number 392012 Kanazawa-Shi, Japan Sanofi-Aventis Investigational Site Number 392001 Kawaguchi-Shi, Japan Sanofi-Aventis Investigational Site Number 392003 Kawasaki-Shi, Japan Sanofi-Aventis Investigational Site Number 392004 Kawasaki-Shi, Japan Sanofi-Aventis Investigational Site Number 392002 Kita-Ku, Japan Sanofi-Aventis Investigational Site Number 392011 Kofu-Shi, Japan Sanofi-Aventis Investigational Site Number 392014 Obu-Shi, Japan Sanofi-Aventis Investigational Site Number 392013 Seki-Shi, Japan Sanofi-Aventis Investigational Site Number 392005 Yokohama-Shi, Japan Sanofi-Aventis Investigational Site Number 392006 Yokohama-Shi, Japan Sanofi-Aventis Investigational Site Number 392007 Yokohama-Shi, Japan Sanofi-Aventis Investigational Site Number 392008 Yokohama-Shi, Japan Sanofi-Aventis Investigational Site Number 392009 Yokohama-Shi, Japan Sanofi-Aventis Investigational Site Number 392010 Yokohama-Shi, Japan Less <<
NCT00420082 Seasonal Allergic Rhinitis Phase 2 Completed - Austria ... More >> Allergy Center Vienna West Vienna, Austria, A-1150 Less <<
NCT01856348 Physiological Effects of Vitam... More >>in D Less << Phase 1 Completed - Switzerland ... More >> University Hospital Zurich, Dept. of Clinical Pharmacology and Toxicology Zurich, ZH, Switzerland, 8091 Less <<
NCT03183297 Veisalgia Phase 1 Not yet recruiting December 2017 -
NCT03012763 Pharmacokinetics ... More >> Magnetic Resonance Imaging Administration, Oral Less << Phase 1 Completed - -
NCT01228630 Perennial Allergic Rhinitis Phase 3 Completed - Brazil ... More >> Lal Clínica Pesquisa E Desenvolvimento Ltda Valinhos, Sao Paulo, Brazil, 13270-245 Less <<
NCT03613246 - Not yet recruiting November 2022 -
NCT00045955 Asthma Phase 3 Completed - United States, New Jersey ... More >> Aventis Pharmaceutical Inc. Bridgewater, New Jersey, United States, 08807 Less <<
NCT01306721 Rhinitis Seasonal Phase 3 Completed - Japan ... More >> Investigational Site Number 392002 Koganei-Shi, Japan Investigational Site Number 392003 Osaka-Shi, Japan Investigational Site Number 392001 Shinjuku-Ku, Japan Less <<
NCT00044824 Asthma Phase 3 Completed - United States, New Jersey ... More >> Aventis Pharmaceuticals Inc. Bridgewater, New Jersey, United States, 08807 Costa Rica Sanofi-Aventis Admnistrative Office Costa Rica, Costa Rica Guatemala Sanofi-Aventis Administrative Office Guatemala City, Guatemala Hungary sanofi-aventis Hungaria Budapest, Hungary Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Poland sanofi-aventis Poland Warszawa, Poland Russian Federation Sanofi-Aventis Aministrative Office Moscow, Russian Federation Less <<
NCT02175485 Rhinitis Allergic Phase 4 Completed - Japan ... More >> Investigational Site Number 392-001 Shinjuku-ku, Japan Less <<
NCT01244230 Atopic Dermatitis Phase 2 Phase 3 Completed - Japan ... More >> Investigational Site Number 392012 Hitachinaka-Shi, Japan Investigational Site Number 392001 Isumi-Shi, Japan Investigational Site Number 392010 Itoshima-Shi, Japan Investigational Site Number 392002 Katsushika-Ku, Japan Investigational Site Number 392006 Kofu-Shi, Japan Investigational Site Number 392011 Komae-Shi, Japan Investigational Site Number 392007 Komatsu-Shi, Japan Investigational Site Number 392003 Koto-Ku, Japan Investigational Site Number 392013 Nagano-Shi, Japan Investigational Site Number 392009 Okayama-Shi, Japan Investigational Site Number 392008 Osaka-Shi, Japan Investigational Site Number 392004 Setagaya-Ku, Japan Investigational Site Number 392005 Setagaya-Ku, Japan Less <<
NCT00638118 Allergic Rhinitis Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT02171546 Healthy Phase 1 Terminated - -
NCT00637585 Allergic Rhinitis Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT01469234 Rhinitis Phase 4 Completed - -
NCT00647985 Healthy Phase 1 Completed - United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less <<
NCT03287856 Transcatheter Aortic Valve Imp... More >>lantation Less << Not Applicable Recruiting October 2019 Germany ... More >> Universit?ts-Herzzentrum Freiburg-Bad Krozingen Not yet recruiting Bad Krozingen, Germany Segeberger Kliniken, Herzzentrum Not yet recruiting Bad Segeberg, Germany Immanuel Klinik Bernau Herzzentrum Brandenburg Not yet recruiting Bernau bei Berlin, Germany Mitteldeutsches Herzzentrum Universit?tsklinikum Halle (Saale) Not yet recruiting Halle (Saale), Germany Asklepios Klinik St. Georg Not yet recruiting Hamburg, Germany Universit?res Herzzentrum Hamburg GmbH Recruiting Hamburg, Germany Herzzentrum Leipzig GmbH Universit?tsklinik Not yet recruiting Leipzig, Germany Klinikum Oldenburg A?R Not yet recruiting Oldenburg, Germany Less <<
NCT01469234 - Completed - -
NCT00261079 Pruritus Phase 4 Completed - Korea, Republic of ... More >> Handok Seoul, Korea, Republic of Less <<
NCT01172522 Edema Phase 2 Completed - United States, New Jersey ... More >> TKL Research Paramus, New Jersey, United States, 07652 Less <<
NCT00044811 Asthma Phase 3 Completed - United States, New Jersey ... More >> Aventis Pharmaceuticals Inc. Bridgewater, New Jersey, United States, 08807 Costa Rica Sanofi-Aventis Admnistrative Office Costa Rica, Costa Rica Guatemala Sanofi-Aventis Administrative Office Guatemala City, Guatemala Hungary Sanofi-Aventis Administrative Office Budapest, Hungary Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Poland Sanofi-Aventis Administrative Office Warszawa, Poland Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Less <<
NCT01172522 - Completed - -
NCT00435461 Rhinitis, Allergic, Seasonal Phase 4 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78731 GSK Investigational Site Austin, Texas, United States, 78750 GSK Investigational Site Kerrville, Texas, United States, 78028 GSK Investigational Site New Braunfels, Texas, United States, 78130 GSK Investigational Site San Antonio, Texas, United States, 78205 GSK Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT00637884 Cat Induced Allergic Rhinitis PHASE4 COMPLETED 2025-02-04 -
NCT00783211 Seasonal Allergic Rhinitis Phase 4 Completed - -
NCT00783146 Seasonal Allergic Rhinitis Phase 4 Completed - -
NCT00649376 Healthy Phase 1 Completed - United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less <<
NCT01526213 Food-drug Interaction Not Applicable Completed - United States, North Carolina ... More >> North Carolina Clinical and Translational Research Center Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00435461 - Completed - -
NCT00502775 Rhinitis, Allergic, Seasonal Phase 4 Completed - -
NCT01526213 - Completed - -
NCT01298505 Healthy Phase 1 Terminated(This study was stop... More >>ped due to lack of evidence for clinical efficacy.) Less << - Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less <<
NCT00741897 Rhinitis, Allergic, Perennial Phase 4 Completed - Philippines ... More >> Sanofi-aventis administrative office Makati City, Philippines Less <<
NCT00502775 - Completed - -
NCT00835640 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58102 Less <<
NCT00835640 - Completed - -
NCT00835276 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58102 Less <<
NCT02157558 Drug Interactions Phase 1 Completed - United States, Texas ... More >> Lexicon Investigational Site Dallas, Texas, United States, 75247 Less <<
NCT03108274 Drug Interaction Potentiation Phase 1 Completed - New Zealand ... More >> Auckland Clinical Studies Auckland, New Zealand, 1150 Less <<
NCT02551536 Allergic Rhinitis Phase 4 Completed - -
NCT00636870 Allergic Rhinitis Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT00835276 - Completed - -
NCT00783133 Seasonal Allergic Rhinitis Phase 4 Completed - -
NCT00794248 Seasonal Allergic Rhinitis Phase 4 Completed - -
NCT01586091 Allergic Rhinitis Phase 1 Completed - Germany ... More >> University of Berlin Charité Berlin, Germany, 10117 Less <<
NCT00637455 Seasonal Allergic Rhinitis Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT00794768 Seasonal Allergic Rhinitis Phase 4 Completed - -
NCT00637611 Seasonal Allergic Rhinitis PHASE4 COMPLETED 2025-04-03 Sanofi-Aventis, Bridgewater, N... More >>ew Jersey, 08807, United States Less <<
NCT03664882 Rhinitis Seasonal Phase 3 Recruiting February 2019 Canada ... More >> Investigational Site Number Recruiting Canada, Canada Less <<
NCT03425097 Gastroesophageal Reflux Phase 2 Recruiting May 2019 United States, California ... More >> Silicon Valley Gastroenterology 2490 Hospital Dr. Suite 211 Recruiting Mountain View, California, United States, 94040 Contact: George Triadafilopoulos, MD ?? 650-988-7530 ?? vagt@stanford.edu Less <<
NCT01767272 Healthy Not Applicable Completed - -
NCT03078777 Hemodialysis Phase 4 Recruiting August 2020 Canada, Ontario ... More >> London Health Sciences Centre Recruiting London, Ontario, Canada, N6A5A5 Contact: Brad Urquhart, PhD ?? 5196613756 ?? Brad.Urquhart@schulich.uwo.ca Less <<
NCT01133470 Healthy Phase 1 Completed - India ... More >> Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujrat, India, 380015 Less <<
NCT01133483 Healthy Phase 1 Completed - India ... More >> Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujrat, India, 380015 Less <<
NCT02908750 Non Small Cell Lung Cancer Phase 1 Active, not recruiting March 13, 2019 France ... More >> Research Site Rennes Cedex 9, France, 35033 Korea, Republic of Research Site Seongnam-si, Korea, Republic of, 13620 Research Site Seoul, Korea, Republic of, 05505 Spain Research Site Madrid, Spain, 28040 Research Site Madrid, Spain, 28046 Research Site Madrid, Spain, 28050 Research Site Sevilla, Spain, 41013 Less <<
NCT01888718 Healthy Phase 1 Completed - India ... More >> Bioserve Clinical Research Private Limited Balanagar, Hyderabad, Andhra Pradesh, India, 500 037 Less <<
NCT01066767 Healthy Phase 1 Completed - Canada ... More >> Anapharm Inc., Sainte-Foy Quebec, Canada, G1V 2K8 Less <<
NCT01066754 Healthy Phase 1 Completed - Canada ... More >> Anapharm Inc., Sainte-Foy Quebec, Canada, G1V 2K8 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.86mL

0.37mL

0.19mL

9.29mL

1.86mL

0.93mL

18.58mL

3.72mL

1.86mL

References

 

Historical Records

Categories